By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Agenus (Formerly known as Antigenics Inc. - Lexington, MA) 

3 Forbes Road

Lexington  Massachusetts  02421  U.S.A.
Phone: 781-721-3500 Fax: 781-938-6496


SEARCH JOBS


Industry
Biotechnology






Company News
Phase I/II Clinical Trial Of Agenus (AGEN)' Anti-PD-1 Antibody Begins 4/20/2017 7:21:05 AM
Agenus (AGEN) Commences Phase I Trial With Neoantigen Cancer Vaccine AutoSynVax 4/5/2017 8:47:38 AM
Agenus (AGEN) Commences Phase I Trial With Neoantigen Cancer Vaccine AutoSynVax 4/5/2017 8:04:12 AM
Massachusetts' Agenus (AGEN) to Phase Out 20% of Jobs, Shutter Switzerland Facility in Restructuring 3/30/2017 5:47:01 AM
Agenus (AGEN) Reports Fourth Quarter And Full Year 2016 Results 3/9/2017 11:24:28 AM
Agenus (AGEN) To Report Fourth Quarter And Year End 2016 Financial Results On March 9, 2017; Conference Call To Follow 3/2/2017 10:02:57 AM
Massachusetts' Agenus (AGEN) Quietly Discloses Failure of Cancer Vaccine Trial 2/22/2017 6:33:54 AM
Massachusetts Agenus (AGEN) Gets a Sweetened $510 Million Deal From Incyte (INCY) 2/14/2017 5:44:52 AM
Agenus (AGEN) Appoints Jean-Marie Cuillerot, M.D. Chief Medical Officer 1/30/2017 8:13:41 AM
Agenus (AGEN) Announces Commencement Of Phase 1/2 Clinical Trial Of Anti-OX40 Checkpoint Antibody INCAGN1949 In Patients With Solid Tumors 11/30/2016 6:59:26 AM
12345678910...
//-->